Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Poniard Pharmaceuticals, Inc. (PARD)
USD0.00
+0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address
300 Elliott Avenue West 98119
Seattle, WA, US
Seattle, WA, US
CEO
Robert F. Caspari
Website
poniard.com
IPO
1988-08-11
ISIN US7324494001
Description
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
47
Beta
-36.63
Float Shares
1.48M
Free Float %
99.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +900.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | -99.75% | -99.92% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-88.17
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+49.6% ★ Q3'11: +53.8% (vs Q3'10)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-462.2%
-
Share dilution Biotechnology: -3.4%+32.9% Q3'11: +24.2% (vs Q3'10)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.06× Q3'11: -0.12× (vs Q3'10)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
|---|---|---|
| Revenue |
—
est.
|
—
est.
|
| EBITDA |
—
est.
|
—
est.
|
| EBIT |
—
est.
|
—
est.
|
| Net Income |
—
est.
|
—
est.
|
| SGA |
—
est.
|
—
est.
|
| EPS |
—
est.
|
—
est.
|
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.46M
OE per share TTM
-7.76
Owner's Yield
-6,979,216.15%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1,011.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-03-27 | PERRY MICHAEL S | Officer | S-Sale | D | Common Stock (PARD) | 1,599 | 0.83 | 1.3K | 8,920 | — | ↗ |
| 2012-03-26 | PERRY MICHAEL S | Officer | M-Exempt | A | Common Stock | 2,800 | 0.00 | — | 10,519 | — | ↗ |
| 2012-02-16 | PERRY MICHAEL S | Officer | S-Sale | D | Common Stock (PARD) | 6,346 | 0.87 | 5.5K | 7,719 | — | ↗ |
| 2012-02-15 | PERRY MICHAEL S | Officer | M-Exempt | A | Common Stock | 12,019 | 0.00 | — | 14,065 | — | ↗ |
| 2011-10-06 | MARTELL RON | Director / Officer | M-Exempt | A | Common Stock (PARD) | 25,000 | 0.00 | — | 548,073 | — | ↗ |
| 2011-07-11 | LYONS GARY A | Director | M-Exempt | A | Common Stock | 85,000 | 0.00 | — | 206,145 | — | ↗ |
| 2011-06-09 | Stevens David R | Director | M-Exempt | D | Restricted Stock Units | 36,145 | 0.00 | — | 36,144 | — | ↗ |
| 2011-06-09 | McMahon Gerald PhD | Director | M-Exempt | A | Common Stock (PARD) | 36,145 | 0.00 | — | 55,753 | — | ↗ |
| 2011-06-09 | LYONS GARY A | Director | M-Exempt | D | Restricted Stock Units | 36,145 | 0.00 | — | 36,144 | — | ↗ |
| 2011-06-09 | GOLDFISCHER CARL | Director | M-Exempt | D | Restricted Stock Units | 36,145 | 0.00 | — | 36,144 | — | ↗ |
| 2011-06-09 | CRAVES FRED B | Director | M-Exempt | D | Restricted Stock Units | 36,145 | 0.00 | — | 36,144 | — | ↗ |
| 2011-04-13 | PERRY MICHAEL S | Officer | S-Sale | D | Common Stock (PARD) | 45,140 | 0.37 | 16.9K | 81,860 | — | ↗ |
| 2011-04-09 | PERRY MICHAEL S | Officer | M-Exempt | D | Restricted Stock Units | 112,000 | 0.00 | — | 112,000 | — | ↗ |
| 2011-04-09 | MARTELL RON | Director / Officer | M-Exempt | A | Common Stock | 162,500 | 0.00 | — | 523,073 | — | ↗ |
| 2011-03-14 | PERRY MICHAEL S | Officer | A-Award | A | Restricted Stock Units | 224,000 | 0.00 | — | 224,000 | — | ↗ |
| 2011-02-15 | PERRY MICHAEL S | Officer | A-Award | A | Restricted Stock Units | 480,770 | 0.00 | — | 480,770 | — | ↗ |
| 2011-02-15 | MARTELL RON | Director / Officer | A-Award | A | Restricted Stock Units | 576,924 | 0.00 | — | 576,924 | — | ↗ |
| 2011-02-07 | MARTELL RON | Director / Officer | M-Exempt | A | Common Stock (PARD) | 31,250 | 0.00 | — | 360,573 | — | ↗ |
| 2010-12-31 | MARTELL RON | Director / Officer | M-Exempt | A | Common Stock | 292,208 | 0.00 | — | 304,323 | — | ↗ |
| 2010-10-06 | MARTELL RON | Director / Officer | M-Exempt | A | Common Stock (PARD) | 25,000 | 0.00 | — | 329,323 | — | ↗ |
| 2010-07-30 | PERRY MICHAEL S | Officer | A-Award | A | Common Stock (PARD) | 7,500 | 0.00 | — | 15,000 | — | ↗ |
| 2010-07-12 | LYONS GARY A | Director | M-Exempt | A | Common Stock (PARD) | 85,000 | 0.00 | — | 85,000 | — | ↗ |
| 2010-06-09 | Stevens David R | Director | A-Award | A | Restricted Stock Units | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-06-09 | SIMON NICHOLAS J III | Director / 10% Owner | A-Award | A | Common Stock | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-06-09 | McMahon Gerald PhD | Director | A-Award | A | Restricted Stock Units | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-06-09 | MARTELL RON | Director / Officer | A-Award | A | Restricted Stock Units | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2010-06-09 | LYONS GARY A | Director | A-Award | A | Restricted Stock Units | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-06-09 | GOLDFISCHER CARL | Director | A-Award | A | Restricted Stock Units | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-06-09 | CRAVES FRED B | Director | A-Award | A | Restricted Stock Unit | 72,289 | 0.00 | — | 72,289 | — | ↗ |
| 2010-04-20 | PERRY MICHAEL S | Officer | A-Award | A | Common Stock | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2010-04-09 | MARTELL RON | Director / Officer | A-Award | A | Restricted Stock Units | 325,000 | 0.00 | — | 1,675,541 | — | ↗ |
| 2010-03-25 | MARTELL RON | Director / Officer | P-Purchase | A | Poniard Common Stock | 1,200 | 1.26 | 1.5K | 1,200 | — | ↗ |
| 2010-02-05 | PERRY MICHAEL S | Officer | A-Award | A | Stock Option | 500,000 | 1.60 | 800.0K | 515,000 | — | ↗ |
| 2010-02-04 | WEAVER GREGORY L | Officer | A-Award | A | Restricted Stock Units | 188,312 | 0.00 | — | 398,312 | — | ↗ |
| 2010-02-04 | MARTELL RON | Director / Officer | A-Award | A | Restricted Stock Units | 292,208 | 0.00 | — | 1,350,541 | — | ↗ |
| 2009-11-09 | SIMON NICHOLAS J III | Director / 10% Owner | S-Sale | D | Common Stock | 152,052 | 8.50 | 1.29M | 6,363,249 | — | ↗ |
| 2009-11-09 | MPM BIOVENTURES III LLC | 10% Owner | S-Sale | D | Common Stock | 152,052 | 8.50 | 1.29M | 6,363,249 | — | ↗ |
| 2009-11-09 | EVNIN LUKE | 10% Owner | S-Sale | D | Common Stock | 152,052 | 8.50 | 1.29M | 6,363,249 | — | ↗ |
| 2009-11-06 | SIMON NICHOLAS J III | Director / 10% Owner | S-Sale | D | Common Stock | 264,648 | 8.06 | 2.13M | 6,515,301 | — | ↗ |
| 2009-11-06 | MPM BIOVENTURES III LLC | 10% Owner | S-Sale | D | Common Stock | 264,648 | 8.06 | 2.13M | 6,515,301 | — | ↗ |
| 2009-11-06 | EVNIN LUKE | 10% Owner | S-Sale | D | Common Stock | 264,648 | 8.06 | 2.13M | 6,515,301 | — | ↗ |
| 2009-11-05 | SIMON NICHOLAS J III | Director / 10% Owner | S-Sale | D | Common Stock | 78,262 | 8.00 | 626.3K | 6,779,949 | — | ↗ |
| 2009-11-05 | MPM BIOVENTURES III LLC | 10% Owner | S-Sale | D | Common Stock | 78,262 | 8.00 | 626.3K | 6,779,949 | — | ↗ |
| 2009-11-05 | EVNIN LUKE | 10% Owner | S-Sale | D | Common Stock | 78,262 | 8.00 | 626.3K | 6,779,949 | — | ↗ |
| 2009-10-06 | MARTELL RON | Director / Officer | A-Award | A | Restricted Stock Units | 100,000 | 0.00 | — | 1,058,333 | — | ↗ |
| 2009-08-21 | WEAVER GREGORY L | Officer | P-Purchase | A | Poniard Common Stock | 900 | 7.40 | 6.7K | 10,000 | — | ↗ |
| 2009-07-11 | LYONS GARY A | Director | A-Award | A | Restricted Stock Units | 170,000 | 0.00 | — | 200,000 | — | ↗ |
| 2009-07-07 | LYONS GARY A | Director | — | D | Poniard Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-06-24 | Stevens David R | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.70 | 70.5K | 95,831 | — | ↗ |
| 2009-06-24 | SIMON NICHOLAS J III | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 15,000 | 4.70 | 70.5K | 15,000 | — | ↗ |
| 2009-06-24 | GOLDFISCHER CARL | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.70 | 70.5K | 137,494 | — | ↗ |
| 2009-06-24 | CRAVES FRED B | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.70 | 70.5K | 109,161 | — | ↗ |
| 2009-04-06 | WEAVER GREGORY L | Officer | P-Purchase | A | Common Stock | 1,575 | 2.07 | 3.3K | 6,775 | — | ↗ |
| 2009-03-27 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 100 | 2.13 | 213.00 | 202,603 | — | ↗ |
| 2009-03-26 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 1,900 | 2.09 | 4.0K | 190,503 | — | ↗ |
| 2009-02-18 | WEAVER GREGORY L | Officer | — | D | Poniard Common Stock | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2009-01-09 | Stevens David R | Director | P-Purchase | A | Common Stock | 100 | 3.41 | 341.00 | 13,668 | — | ↗ |
| 2008-12-30 | McMahon Gerald PhD | Director / Officer | P-Purchase | A | Common Stock | 4,300 | 1.30 | 5.6K | 19,608 | — | ↗ |
| 2008-12-29 | McMahon Gerald PhD | Director / Officer | P-Purchase | A | Common Stock | 7,375 | 1.40 | 10.3K | 12,108 | — | ↗ |
| 2008-12-22 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 600 | 1.81 | 1.1K | 143,200 | — | ↗ |
| 2008-12-19 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 2,500 | 1.72 | 4.3K | 120,800 | — | ↗ |
| 2008-12-18 | McMahon Gerald PhD | Director / Officer | A-Award | A | Stock Option | 125,000 | 1.78 | 222.5K | 1,450,230 | — | ↗ |
| 2008-12-18 | MARTELL RON | Director / Officer | A-Award | A | Stock Option | 75,000 | 1.78 | 133.5K | 958,333 | — | ↗ |
| 2008-12-18 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 800 | 1.91 | 1.5K | 89,600 | — | ↗ |
| 2008-12-17 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 200 | 1.94 | 388.00 | 85,900 | — | ↗ |
| 2008-12-16 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 100 | 1.94 | 194.00 | 70,600 | — | ↗ |
| 2008-06-24 | Stevens David R | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.40 | 66.0K | 15,000 | — | ↗ |
| 2008-06-24 | SIMON NICHOLAS J III | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 15,000 | 4.40 | 66.0K | 15,000 | — | ↗ |
| 2008-06-24 | GOLDFISCHER CARL | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.40 | 66.0K | 15,000 | — | ↗ |
| 2008-06-24 | CRAVES FRED B | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 4.40 | 66.0K | 15,000 | — | ↗ |
| 2008-03-06 | McMahon Gerald PhD | Director / Officer | P-Purchase | A | Common Stock | 3,900 | 3.93 | 15.3K | 4,733 | — | ↗ |
| 2008-03-06 | Loewy Caroline M | Officer | P-Purchase | A | Common Stock | 100 | 3.94 | 394.00 | 30,000 | — | ↗ |
| 2008-03-05 | Loewy Caroline M | Officer | P-Purchase | A | Common Stock | 404 | 3.73 | 1.5K | 21,604 | — | ↗ |
| 2008-03-04 | Loewy Caroline M | Officer | P-Purchase | A | Common Stock | 1,000 | 3.63 | 3.6K | 19,600 | — | ↗ |
| 2008-01-15 | Stevens David R | Director | P-Purchase | A | Common Stock | 3,809 | 5.25 | 20.0K | 13,368 | — | ↗ |
| 2008-01-11 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 100 | 3.87 | 387.00 | 51,400 | — | ↗ |
| 2008-01-09 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 1,900 | 4.23 | 8.0K | 51,300 | — | ↗ |
| 2008-01-04 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 300 | 4.16 | 1.2K | 25,065 | — | ↗ |
| 2008-01-03 | McMahon Gerald PhD | Director / Officer | A-Award | A | Stock Option | 125,000 | 4.18 | 522.5K | 125,000 | — | ↗ |
| 2008-01-03 | MARTELL RON | Director / Officer | A-Award | A | Stock Option | 75,000 | 4.18 | 313.5K | 75,000 | — | ↗ |
| 2008-01-03 | Loewy Caroline M | Officer | A-Award | A | Stock Option | 60,000 | 4.18 | 250.8K | 60,000 | — | ↗ |
| 2008-01-03 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 400 | 4.29 | 1.7K | 400 | — | ↗ |
| 2007-08-30 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 5 | 5.74 | 28.70 | 274,749 | — | ↗ |
| 2007-08-30 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 36 | 5.75 | 207.00 | 395,784 | — | ↗ |
| 2007-08-29 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 240 | 5.75 | 1.4K | 271,100 | — | ↗ |
| 2007-08-29 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 346 | 5.75 | 2.0K | 390,532 | — | ↗ |
| 2007-08-16 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 223 | 5.48 | 1.2K | 270,859 | — | ↗ |
| 2007-08-16 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 322 | 5.48 | 1.8K | 390,186 | — | ↗ |
| 2007-08-14 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 28 | 5.50 | 154.00 | 270,636 | — | ↗ |
| 2007-08-14 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 1 | 5.50 | 5.50 | 6,424 | — | ↗ |
| 2007-08-10 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 664 | 5.50 | 3.7K | 270,608 | — | ↗ |
| 2007-08-10 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 956 | 5.50 | 5.3K | 389,824 | — | ↗ |
| 2007-06-14 | Stevens David R | Director | A-Award | A | Stock Option | 15,000 | 7.17 | 107.6K | 15,000 | — | ↗ |
| 2007-06-14 | SIMON NICHOLAS J III | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 15,000 | 7.17 | 107.6K | 15,000 | — | ↗ |
| 2007-06-14 | McMahon Gerald PhD | Director / Officer | A-Award | A | Stock Option | 284,400 | 3.66 | 1.04M | 284,400 | — | ↗ |
| 2007-06-14 | MARTELL RON | Director / Officer | A-Award | A | Stock Option | 800,000 | 6.87 | 5.50M | 800,000 | — | ↗ |
| 2007-06-14 | Loewy Caroline M | Officer | A-Award | A | Stock Option | 60,000 | 8.14 | 488.4K | 60,000 | — | ↗ |
| 2007-06-14 | GOLDFISCHER CARL | Director | A-Award | A | Stock Option | 15,000 | 7.17 | 107.6K | 15,000 | — | ↗ |
| 2007-06-14 | CRAVES FRED B | Director | A-Award | A | Stock Option | 15,000 | 7.17 | 107.6K | 15,000 | — | ↗ |
| 2007-04-30 | SIMON NICHOLAS J III | Director / 10% Owner | P-Purchase | A | Common Stock | 900,000 | 6.33 | 5.70M | 6,858,211 | — | ↗ |
| 2007-04-30 | MPM BIOVENTURES III LLC | 10% Owner | P-Purchase | A | Common Stock | 900,000 | 6.33 | 5.70M | 6,858,211 | — | ↗ |
| 2007-04-30 | GOLDFISCHER CARL | Director | P-Purchase | A | Common Stock | 54,291 | 6.33 | 343.7K | 269,944 | — | ↗ |
| 2007-04-30 | EVNIN LUKE | 10% Owner | P-Purchase | A | Common Stock | 900,000 | 6.33 | 5.70M | 6,858,211 | — | ↗ |
| 2007-04-30 | CRAVES FRED B | Director | P-Purchase | A | Common Stock | 78,209 | 6.33 | 495.1K | 388,868 | — | ↗ |
| 2006-06-26 | MARTELL RON | Director | — | D | Poniard Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2006-06-23 | Loewy Caroline M | Officer | A-Award | A | Stock Option | 600,000 | 1.00 | 600.0K | 600,000 | — | ↗ |
| 2006-06-16 | Stevens David R | Director | A-Award | A | Stock Option | 45,000 | 1.08 | 48.6K | 45,000 | — | ↗ |
| 2006-06-16 | McMahon Gerald PhD | Officer | A-Award | A | Stock Option | 1,000,000 | 1.08 | 1.08M | 1,000,000 | — | ↗ |
| 2006-06-16 | GOLDFISCHER CARL | Director | A-Award | A | Stock Option | 45,000 | 1.08 | 48.6K | 45,000 | — | ↗ |
| 2006-06-16 | CRAVES FRED B | Director | A-Award | A | Stock Option | 45,000 | 1.08 | 48.6K | 45,000 | — | ↗ |
| 2005-02-27 | Loewy Caroline M | Officer | — | D | Stock Option | 50,000 | 2.24 | 112.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
1.50M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paul G. Abrams | Executive Officer | — | — |
| Robert F. Caspari | Executive Officer | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PARD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
